Home/ Stocks/ BDRX

Biodexa Pharmaceuticals plc American Depositary Shs

BDRX XNAS

$2.94 +0.00 (+0.00%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$2.44M

About Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Employees: 11 Website →

Earnings & Analyst Ratings

Next Earnings: Thu, Sep 10, 2026

Calendar →

TickerDaily Coverage

Why Is Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) Stock Up 69.4% Today?

Penny Stocks Marcus Rivera · Apr 2, 2026

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) exploded 69.4% on Thursday, April 2,...

Stock Market Today, April 3, 2026: Weekly Recap of Explosive Penny Stock Moves

Market News David Brooks · Apr 3, 2026

Friday, April 3, 2026 marked the close of a volatile week dominated by biotech and micro-cap...

View All Coverage →

Get BDRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Biodexa Pharmaceuticals plc American Depositary Shs.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.